Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targetsJing Hua Zhao, James E. Peters, Lasse Folkersen et al.|Nature Immunology|2023Cited by 724
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002Christian Herder, Barbara Thorand|Diabetologia|2007Cited by 92
Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 StudyHong Luo, Barbara Thorand, Alina Bauer et al.|Diabetologia|2023Cited by 59
Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA studyHong Luo, Barbara Thorand, Marie‐Theres Huemer et al.|Cardiovascular Diabetology|2024Cited by 16
Incremental utility of circulating biomarkers for cardiovascular risk prediction beyond the updated SCORE2 modelJonas Lehmacher, Raphael Twerenbold, Betül Toprak et al.|European Heart Journal|2022Cited by 1